Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

A Phase 2b Trial of EPB-348 for the Treatment of Herpes Zoster

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Epiphany Biosciences
ClinicalTrials.gov Identifier:
NCT00831103
First received: January 26, 2009
Last updated: December 3, 2013
Last verified: December 2013